Startup developing treatments for Tourette syndrome and stuttering raises $35M

A Chicago biotech startup that's developing treatments for central nervous system movement disorders raised a round of funding to bring its therapies to market.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.